Mass spectrometry is the gold standard for complex metabolic research. It enables more accurate and faster determination of molecular mass and the measurement of dozens of substances in a single biological sample.

The new kits will allow for precise assessment of hormone levels, vitamins, lipids, amino acids, and other substances in the human body, reducing dependence on imported reagents and equipment in clinical diagnostic laboratories. They are planned for use in cardiology, endocrinology, neonatology, oncology, nutritiology, perinatal screening, and therapeutic drug monitoring.

The first kits for analyzing vitamins and polyunsaturated fatty acids in the blood have already passed trials. Sechenov Center of Maternity and Childhood has already implemented these kits to evaluate fatty acid metabolism in women, supporting the optimization of infant nutrition.

Further developments will include kits for evaluating hormonal profiles, cancer markers, and monitoring drug concentrations in the blood.